IL6 and neoplasm: Pro-inflammatory cytokines (e.g., IL-1, IL-6) drive thrombocytosis 33, 34, and elevated platelet counts coupled with altered PLR values may reflect both systemic inflammation and tumor microenvironment modulation 35.